Evidence map›Paper›PMID 33629208›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2021

Beyond price: the effects of non-financial barriers on access to drugs and health outcomes.

Lucia Leporatti, Rosella Levaggi, Marcello Montefiori

Abstract read
PubMed Publisher
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Predicting pharmacy choice for managed care network design.Journal of managed care & specialty pharmacy · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lucia LeporattiDepartment of Economics and Business Studies, University of Genoa, Via Vivaldi 5, 16126, Genoa, Italy.ORCID http://orcid.org/0000-0003-4186-908X
Rosella LevaggiDepartment of Economics and Management, University of Brescia, Via San Faustino 74b, 25122, Brescia, Italy.ORCID http://orcid.org/0000-0002-6018-1283
Marcello MontefioriDepartment of Economics and Business Studies, University of Genoa, Via Vivaldi 5, 16126, Genoa, Italy. montefiori@unige.it.ORCID http://orcid.org/0000-0002-7288-9641

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe study the impact of the pharmacy dispensing channel (as a proxy for access to drugs) on the drug purchases, health outcomes, and health care utilization (emergency room visits or hospitalizations) of chronically ill patients in Liguria, Italy, in 2017.

methodsWe use the coarsened exact matching algorithm to compare the health outcomes for a treated group of patients living in a local health authority (LHA) where drug distribution through community pharmacies was restricted. These patients were matched to a control group of patients living in other LHAs, where drugs were also dispensed through a broad network of community pharmacies. We exploit a unique administrative dataset with information on the socio-demographic characteristics and health care services utilization of Ligurian patients with chronic cardiovascular and respiratory ailments. We restrict our analysis to patients 65 years of age or older who were admitted to hospitals from 2013 to 2016 with either a principal or secondary diagnosis connected to chronic cardiovascular and respiratory diseases.

resultsReduced access to drugs leads to lowered drug consumption, a higher probability of adverse health outcomes including mortality, and a higher consumption of medical services in terms of hospitalizations and emergency room visits. These effects increase with patients' age.

conclusionThe pharmacy dispensing channel significantly affects drug consumption and acts as a proxy for adherence among chronically ill patients. Thus, health outcomes and health care utilization should be carefully evaluated when comparing the costs of alternative dispensing channels.

Indexed as

Pharmaceutical PreparationsPharmaciesHospitalizationHumansItalyOutcome Assessment, Health CarePharmaceutical PreparationsAccess to drugsAgingChronic conditionHealth outcomePharmaceutical dispensing channel

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.